ArticlePloS one2025
A methodology for calculating the rarity of diverse proteins based on functional specificity and thermodynamic stability.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A key question in protein studies is the proportion of amino acid sequences that correspond to functional proteins, often called protein rarity. This issue underlies the relationship between mutations and disease, theories on the origin of proteins, and strategies for engineering new proteins. Recent literature has detailed how to employ estimates of protein rarity to evaluate the required biasing of functional sequences in sequence space to allow for evolutionary paths to connect distinct proteins. One challenge in addressing rarity has been an imprecise definition of function and a lack of consistency in methodology. This study introduces a new methodology, referred to as PRISM, to evaluate protein rarity based on the impact of mutations on stability. PRISM offers a suite of methods that are simpler than traditional approaches while providing accurate upper-bound rarity estimates. The specific method applied is determined by the protein's function and available empirical data on how accumulating mutations affect its stability and performance. PRISM is applied to several proteins, and the accuracy of the methods is demonstrated by comparing the results to rarity estimates from previous studies. The calculated rarities align with previous research that concludes functional sequences are often exceedingly rare. The application of PRISM is outlined for research in protein engineering, protein evolution, and pathology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.